Literature DB >> 25528477

Binding of trivalent chromium to serum transferrin is sufficiently rapid to be physiologically relevant.

Ge Deng1, Kristi Wu1, Alex A Cruce1, Michael K Bowman1, John B Vincent2.   

Abstract

Transferrin, the major iron transport protein in the blood, also transports trivalent chromium in vivo. Recent in vitro studies have, however, suggested that the binding of chromic ions to apotransferrin is too slow to be biologically relevant. Nevertheless, the in vitro studies have generally failed to adequately take physiological bicarbonate concentrations into account. In aqueous buffer (with ambient (bi)carbonate concentrations), the binding of chromium to transferrin is too slow to be physiologically relevant, taking days to reach equilibrium with the protein's associated conformational changes. However, in the presence of 25mM (bi)carbonate, the concentration in human blood, chromic ions bind rapidly and tightly to transferrin. Details of the kinetics of chromium binding to human serum transferrin and conalbumin (egg white transferrin) in the presence of bicarbonate and other major potential chromium ligands are described and are consistent with transferrin being the major chromic ion transporter from the blood to tissues.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chromium; Conalbumin; Kinetics; Transferrin

Mesh:

Substances:

Year:  2014        PMID: 25528477     DOI: 10.1016/j.jinorgbio.2014.12.004

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  2 in total

1.  Highly Selective Detection of Cr3 + Ion with Colorimetric & Fluorescent Response Via Chemodosimetric Approach in Aqueous Medium.

Authors:  Ganesan Punithakumari; Shu Pao Wu; Sivan Velmathi
Journal:  J Fluoresc       Date:  2018-04-14       Impact factor: 2.217

2.  Significance of conformation changes during the binding and release of chromium(III) from human serum transferrin.

Authors:  Kyle C Edwards; Hannah Kim; Riley Ferguson; Molly M Lockart; John B Vincent
Journal:  J Inorg Biochem       Date:  2020-02-15       Impact factor: 4.155

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.